Ubs Group Ag Iqvia Holdings Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Iqvia Holdings Inc. stock. As of the latest transaction made, Ubs Group Ag holds 11,000 shares of IQV stock, worth $2.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,000

Previous 433,662 97.46%

Holding current value

$2.12 Million

Previous $91.7 Million 97.16%

% of portfolio

0.0%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$206.81 - $251.55 $4.56 Million - $5.54 Million	22,040 Added 5.08%	455,702 $108 Million
Q2 2024 Aug 13, 2024	BUY	$211.18 - $248.87 $13.9 Million - $16.3 Million	65,661 Added 17.84%	433,662 $91.7 Million
Q1 2024 May 13, 2024	BUY	$208.23 - $259.1 $14.2 Million - $17.6 Million	68,023 Added 22.68%	368,001 $93.1 Million
Q4 2023 Feb 09, 2024	SELL	$177.16 - $232.73 $12.3 Million - $16.2 Million	-69,513 Reduced 18.81%	299,978 $69.4 Million
Q3 2023 Nov 09, 2023	SELL	$196.75 - $231.96 $6.39 Million - $7.53 Million	-32,479 Reduced 8.08%	369,491 $72.7 Million
Q2 2023 Aug 11, 2023	BUY	$183.66 - $224.77 $8.51 Million - $10.4 Million	46,319 Added 13.02%	401,970 $90.4 Million
Q1 2023 May 12, 2023	BUY	$188.0 - $240.65 $1.14 Million - $1.46 Million	6,084 Added 1.74%	355,651 $70.7 Million
Q4 2022 Feb 08, 2023	BUY	$172.45 - $226.53 $15.6 Million - $20.5 Million	90,421 Added 34.89%	349,567 $71.6 Million
Q3 2022 Nov 10, 2022	SELL	$181.14 - $248.26 $7.44 Million - $10.2 Million	-41,053 Reduced 13.68%	259,146 $46.9 Million
Q2 2022 Aug 10, 2022	SELL	$196.45 - $252.29 $6.44 Million - $8.27 Million	-32,785 Reduced 9.85%	300,199 $65.1 Million
Q1 2022 May 16, 2022	SELL	$210.56 - $273.58 $11 Million - $14.3 Million	-52,194 Reduced 13.55%	332,984 $77 Million
Q4 2021 Feb 14, 2022	BUY	$238.37 - $282.61 $17.1 Million - $20.3 Million	71,857 Added 22.93%	385,178 $109 Million
Q3 2021 Nov 15, 2021	BUY	$239.54 - $265.23 $7.26 Million - $8.04 Million	30,324 Added 10.72%	313,321 $75.1 Million
Q2 2021 Aug 13, 2021	BUY	$198.06 - $246.77 $3.52 Million - $4.39 Million	17,791 Added 6.71%	282,997 $68.6 Million
Q1 2021 May 12, 2021	BUY	$173.0 - $194.59 $6.85 Million - $7.71 Million	39,600 Added 17.55%	265,206 $51.2 Million
Q4 2020 Feb 11, 2021	BUY	$153.99 - $180.39 $1.13 Million - $1.33 Million	7,347 Added 3.37%	225,606 $40.4 Million
Q3 2020 Nov 12, 2020	BUY	$141.28 - $169.75 $16.7 Million - $20.1 Million	118,523 Added 118.84%	218,259 $34.4 Million
Q2 2020 Jul 31, 2020	BUY	$100.04 - $153.06 $2.27 Million - $3.47 Million	22,670 Added 29.42%	99,736 $14.2 Million
Q1 2020 May 01, 2020	SELL	$84.0 - $166.11 $933,156 - $1.85 Million	-11,109 Reduced 12.6%	77,066 $8.31 Million
Q4 2019 Feb 14, 2020	SELL	$137.59 - $155.95 $3.39 Million - $3.84 Million	-24,626 Reduced 21.83%	88,175 $13.6 Million
Q3 2019 Nov 14, 2019	BUY	$148.25 - $161.46 $3.73 Million - $4.06 Million	25,162 Added 28.71%	112,801 $16.9 Million
Q2 2019 Aug 14, 2019	BUY	$132.28 - $160.9 $1.99 Million - $2.42 Million	15,026 Added 20.69%	87,639 $14.1 Million
Q1 2019 May 14, 2019	BUY	$109.96 - $144.45 $1.43 Million - $1.88 Million	13,002 Added 21.81%	72,613 $10.4 Million
Q4 2018 Feb 14, 2019	BUY	$105.7 - $130.35 $1.82 Million - $2.25 Million	17,260 Added 40.75%	59,611 $6.93 Million
Q3 2018 Nov 14, 2018	SELL	$99.3 - $130.77 $712,874 - $938,797	-7,179 Reduced 14.49%	42,351 $5.5 Million
Q2 2018 Aug 14, 2018	BUY	$94.85 - $105.95 $1.08 Million - $1.2 Million	11,358 Added 29.75%	49,530 $4.94 Million
Q1 2018 May 15, 2018	SELL	$95.23 - $106.01 $1.3 Million - $1.45 Million	-13,687 Reduced 26.39%	38,172 $3.75 Million
Q4 2017 Feb 14, 2018	BUY	$95.0 - $108.56 $4.93 Million - $5.63 Million	51,859	51,859 $5.08 Million

Others Institutions Holding IQV

# of Institutions

1,137

Shares Held

142M

Call Options Held

828K

Put Options Held

951K

View Full List

About IQVIA HOLDINGS INC.

Ticker IQV
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 185,740,000
Market Cap $35.8B
Description
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The ...

More about IQV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account